January 4, 2017 / 10:44 PM / 7 months ago

BRIEF-Aeterna Zentaris announces top-line results of confirmatory Phase 3 trial of Macrilen

1 Min Read

Jan 4 (Reuters) - Aeterna Zentaris Inc

* Aeterna Zentaris announces top-line results of confirmatory Phase 3 trial of Macrilen

* Aeterna Zentaris Inc says evaluating outcome of trial and will determine in near future whether it will continue with development of Macrilen

* Aeterna Zentaris - results did not meet pre-defined equivalence criteria which required success for percent negative agreement, percent positive agreement

* Aeterna Zentaris - we are "disappointed" regarding outcome of trial, will re-direct resources to completion of on-going Phase 3 clinical trial of zoptrex

* Aeterna Zentaris - trial of Macrilen failed to achieve goal of validating single oral dose of macimorelin for evaluation of AGHD using ITT as comparator Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below